Patents Assigned to CFM PHARMA HOLDING BV
  • USE OF VANADIUM COMPOUNDS FOR MAINTAINING NORMAGLYCEMIA IN A MAMMAL
    Publication number: 20220040195
    Abstract: The present invention relates to a method for maintaining normoglycemia in a mammal in need thereof, preferably a critically ill patient suffering from acute stress, and to a method for preventing or limiting renal ischemia-reperfusion (I/R) in a mammal, preferably in a critically ill patient suffering from acute stress.
    Type: Application
    Filed: October 22, 2021
    Publication date: February 10, 2022
    Applicant: CFM Pharma Holding BV
    Inventors: Hendrik Jan Cornelis Meijerink, Lekhram Changoer
  • Use of vanadium compounds for maintaining normaglycemia in a mammal
    Patent number: 11179401
    Abstract: The present invention relates to a method for maintaining normoglycemia in a mammal in need thereof, preferably a critically ill patient suffering from acute stress, and to a method for preventing or limiting renal ischemia-reperfusion (I/R) in a mammal, preferably in a critically ill patient suffering from acute stress.
    Type: Grant
    Filed: September 16, 2019
    Date of Patent: November 23, 2021
    Assignee: CFM PHARMA HOLDING BV
    Inventors: Hendrik Jan Cornelis Meijerink, Lekhram Changoer
  • Use of vanadium compounds for maintaining normaglycemia in a mammal
    Patent number: 10449204
    Abstract: The present invention relates to a method for maintaining normoglycemia in a mammal in need thereof, preferably a critically ill patient suffering from acute stress, and to a method for preventing or limiting renal ischemia-reperfusion (I/R) in a mammal, preferably in a critically ill patient suffering from acute stress.
    Type: Grant
    Filed: March 6, 2012
    Date of Patent: October 22, 2019
    Assignee: CFM PHARMA HOLDING BV
    Inventors: Hendrik Jan Cornelis, Lekhram Changoer